Fast-tracking genetic leads to reverse cellular aging
Summary
DeepMind's Co-Scientist is helping biologists identify genetic factors that reverse cellular aging by mining literature and analyzing screening data, reducing analysis time from months to days.
View Cached Full Text
Cached at: 05/19/26, 07:15 PM
Similar Articles
Opening new paths in aging research
Calico Life Sciences uses Google DeepMind's Co‑Scientist to connect scattered findings in aging biology and generate testable hypotheses, such as a novel hypothesis about ISR regulation by metabolism.
Why “reprogramming” is the buzziest approach to reversing aging right now
A biotech company has dosed its first volunteer in a clinical trial for an experimental glaucoma treatment that uses cellular reprogramming to reverse age-related damage, part of a broader trend toward rejuvenation therapies.
Uniting biological toolkits for a new approach to ALS
DeepMind's Co-Scientist AI tool bridges the expertise of two researchers from different biological fields to accelerate ALS research by generating testable hypotheses and identifying RNA-based mechanisms for potential therapies.
@brian_armstrong: Aging is arguably the root cause of most major diseases (loss of function in our cells). Four years ago, we made a bet …
Brian Armstrong announces that NewLimit has developed a prototype drug that reverses cellular aging in human cells, with a clinical trial scheduled for next year, and has raised $435M in Series C funding led by Founders Fund.
AlphaGenome: AI for better understanding the genome
DeepMind introduces AlphaGenome, an AI model that predicts how DNA sequence variants impact gene regulation and biological processes across diverse cell types and tissues. The model processes up to 1 million base pairs and is available via API for non-commercial research, with the full paper published in Nature.